The use of nicotine replacement therapy in pregnancy has been debated but evidence suggests that it is safer than smoking. A cross-sectional survey was conducted with: (i) general practitioners and obstetricians from a college database; and (ii) general practitioners with a special interest in Indigenous health. General practitioners had higher odds of prescribing compared to obstetricians. Reading guidelines, confidence, viewing nicotine replacement therapy as safe, effective and with good adherence, also significantly increased the odds of prescription. Clear guidance regarding safety and efficacy, with practical clinical protocols, are required in order to reduce variation in prescribing rates across these clinicians.
|Original language||American English|
|Number of pages||5|
|Journal||Australian and New Zealand Journal of Obstetrics and Gynaecology|
|State||Published - Jun 2018|
Bibliographical noteFunding Information:
We would like to acknowledge Professor Yvonne Cadet James, A/ Professor Kerrianne Watt and Dr Marilyn Clarke for their input in the early stages of designing this study; and Ms Harshani Jayasinghe for assisting with the early versions of the survey. This work has been funded by RACGP Chris Silagy Scholarship (Gould) and an NHMRC Early Career Fellowship (Gould), and Hunter Cancer Research Alliance PhD scholarship (Bar-Zeev). [Correction added on 18 December 2017, after first online publication: ‘This work has been funded by RACGP Chris Silagy Scholarship (Gould) and an NHMRC Early Career Fellowship (Gould), and Hunter Cancer Research Alliance PhD scholarship (Bar-Zeev).’ has been added in the Acknowledgements section].
© 2017 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists
- drug therapy
- smoking cessation